FDA Inspection
Upsher-Smith LLCUpsher-Smith LLC – FDA Inspection, Aug 8, 2025
Record Details
This FDA Inspection record concerns Upsher-Smith LLC, with an inspection on August 8, 2025, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · f63e667d-159a-4af8-ae57-9c64f7fb9c1c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1229351
- FDA center
- Human Drugs
- Project area
- Postmarketing Surveillance and Epidemiology: Human Drugs
FDA Citations
2- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Upsher-Smith LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 10, 2026 | NAI | Bioresearch Monitoring |
Other documents for Upsher-Smith LLC
- FDA Inspection 1305670 - 2026-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.